ArticleCureus2026
A Regenerative Breakthrough in the Management of a Cystic Lesion Using a Novel Combination of Eggshell-Derived Nanohydroxyapatite (EnHA) and Concentrated Growth Factor: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eggshell-derived nanohydroxyapatite (EnHA) is an economical, bioactive, and biocompatible bone graft substitute that has been shown to promote active bone formation. It has previously been used in socket preservation and periodontal defects. Autologous blood products such as platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) are being studied extensively for their role in bone regeneration. CGF has shown osteoinductive properties by promoting vascularization and early angiogenesis. Surgical enucleation of a cystic lesion measuring 17.7 × 15.1 mm was performed, followed by grafting of the bony defect using EnHA combined with autologous CGF. Through this case report, we aim to evaluate the feasibility and preliminary outcome of EnHA combined with CGF for bone regeneration in an intrabony defect after removal of a cystic lesion in the posterior mandible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.